Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Diab Vasc Dis Res. 2007 Sep;4 Suppl 3:S2-4.

Clinical implications of the metabolic syndrome.

Author information

  • Centre for Preventive Cardiology, University General Hospital, U Nemocnice 1, Prague, 12808, Czech Republic. Richard.Ceska@vfn.cz

Abstract

The prevalence of the metabolic syndrome among developed countries is rising, and this is largely driven by increasing obesity rates. Central obesity plays a key role in the pathogenesis of the metabolic syndrome: it promotes inflammation, hypertension and dyslipidaemia, and leads to the development of type 2 diabetes mellitus and atherosclerosis. Clinical management should be focused on multifactorial intervention to address all the associated cardiovascular risk factors. The atherogenic mixed dyslipidaemic profile associated with the metabolic syndrome is an important target for intervention to reduce the risk of type 2 diabetes and premature cardiovascular disease.

PMID:
17935057
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk